Owners, management and financials
CVR: 37911143
Previous names: Aktieselskabet af august 2016
DKK 389,681,000
Revenue
Net result: DKK -483,351,000
AJ Vaccines Holding ApS (100%)
CVR · view owners
Ole Vahlgren
Board: Abdulaziz Abdulhamid Abdulrhman Albassam (chair) and 4 members
CVR · view management
Active
Founded 4 August 2016
CVR · view overview
499 employees
CVR · 2026
Director registered: Ole Vahlgren
CVR · 01/02/2022
View the full event history
AJ Vaccines A/S is a Danish company of the type Aktieselskab based in København S, founded in 2016. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Aktieselskabet af august 2016. The management consists of Ole Vahlgren. The board consists of Abdulaziz Abdulhamid Abdulrhman Albassam (chair), Mohammed Ali A Alesayi, Mustafa Nasir Farooki and Saddam Abdulqawi Hussein Alhumaikani. The company is owned by AJ Vaccines Holding ApS. The company has 499 employees (2026). In 2025, the company reported revenue of DKK 389,681,000 and a net result of DKK -483,351,000 compared with DKK -807,117,000 the year before. Equity in the 2025 report amounted to DKK 288,465,000.
Source: annual report 2025, Danish Business Authority
AJ Vaccines A/S is currently facing significant financial challenges, highlighted by a consistent trend of operating losses over the past five years. Revenue peaked at 468,886,000 DKK in 2023 but has since declined to 389,681,000 DKK in 2025, while cumulative losses reached -483,351,000 DKK in the latest year. Despite a robust equity position of 288,465,000 DKK, the company’s profitability remains a concern, with no gross profit data available to assess margins. Positioned within the pharmaceutical manufacturing industry, AJ Vaccines A/S must address its declining revenue and sustained losses to improve its financial trajectory.
AI-generated summary · Generated 15/07/2026
Selskabets formål er at drive virksomhed med udvikling, produktion og handel til indenlandske og udenlandske kunder af vacciner og andre biologiske lægemidler samt anden virksomhed, der efter bestyrelsens skøn er forbundet dermed.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 389.7 mio. | -483.4 mio. | 861.2 mio. | 288.5 mio. | 451 | |
| 202401/01/2024 – 31/12/2024 | 413 mio. | -807.1 mio. | 1.1 mia. | 501.9 mio. | 581 | |
| 202301/01/2023 – 31/12/2023 | 468.9 mio. | -243 mio. | 1.6 mia. | 1 mia. | 577 | |
| 202201/01/2022 – 31/12/2022 | 421 mio. | -268.1 mio. | 1.5 mia. | 994.7 mio. | 556 | |
| 202101/01/2021 – 31/12/2021 | 351.9 mio. | -486.4 mio. | 1.5 mia. | 815.9 mio. | 558 | |
| 202001/01/2020 – 31/12/2020 | 351.6 mio. | -450.2 mio. | 1.7 mia. | 1.1 mia. | 702 | |
| 201901/01/2019 – 31/12/2019 | 323.5 mio. | -288.6 mio. | 1.9 mia. | 1.2 mia. | 719 | |
| 201801/01/2018 – 31/12/2018 | 362.2 mio. | -244.5 mio. | 1.4 mia. | 903.2 mio. | 0 |
Compared to 129 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationThe CVR number of AJ Vaccines A/S is 37911143.
AJ Vaccines A/S is owned by AJ Vaccines Holding ApS.
The management of AJ Vaccines A/S consists of Ole Vahlgren.
The board of AJ Vaccines A/S consists of Abdulaziz Abdulhamid Abdulrhman Albassam, Mohammed Ali A Alesayi and Mustafa Nasir Farooki, with Abdulaziz Abdulhamid Abdulrhman Albassam as chair.
In 2025, AJ Vaccines A/S reported revenue of DKK 389,681,000.
AJ Vaccines A/S had 499 employees in 2026 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
AJ Vaccines A/S has published its annual report for 2025. Revenue came to DKK 389,681,000, and the net result was DKK -483,351,000.
AJ Vaccines A/S has published its annual report for 2024. Revenue came to DKK 412,969,000, and the net result was DKK -807,117,000.
As of July 23, 2024, Tarek Sherif Ahmed Abbas Hegazy has joined the board of directors of AJ Vaccines A/S.
As of July 23, 2024, Shan-E-Abbas Ashary has left the board of directors of AJ Vaccines A/S.
AJ Vaccines A/S has published its annual report for 2023. Revenue came to DKK 468,886,000, and the net result was DKK -242,974,000.
As of August 28, 2023, Abdulaziz Abdulhamid Abdulrhman Albassam has joined the board of directors of AJ Vaccines A/S.
As of August 28, 2023, Abdulaziz Hamad Aljomaih has left the board of directors of AJ Vaccines A/S.
AJ Vaccines A/S has published its annual report for 2022. Revenue came to DKK 420,982,000, and the net result was DKK -268,090,000.
AJ Vaccines A/S has published its annual report for 2021. Revenue came to DKK 351,862,000, and the net result was DKK -486,388,000.
As of February 1, 2022, Shan-E-Abbas Ashary has joined the board of directors of AJ Vaccines A/S.
As of February 1, 2022, Abdulaziz Hamad Aljomaih has joined the board of directors of AJ Vaccines A/S.
As of February 1, 2022, Ole Vahlgren is registered as adm. dir. of AJ Vaccines A/S.
As of February 1, 2022, Jerome Christian Roger Cabannes has stepped down as director of AJ Vaccines A/S.
As of January 31, 2022, Tabassum Khan has left the board of directors of AJ Vaccines A/S.
As of January 31, 2022, Abdulaziz Hamad Aljomaih has left the board of directors of AJ Vaccines A/S.
As of January 31, 2022, Jesper Helmuth Larsen has stepped down as adm. dir. of AJ Vaccines A/S.
AJ Vaccines A/S has published its annual report for 2020. Revenue came to DKK 351,618,000, and the net result was DKK -450,212,000.
As of March 24, 2021, Mohammed Ali A Alesayi has joined the board of directors of AJ Vaccines A/S.
As of March 24, 2021, Abdulaziz Hamad Aljomaih has joined the board of directors of AJ Vaccines A/S.
As of March 24, 2021, Shan-E-Abbas Ashary has left the board of directors of AJ Vaccines A/S.
As of March 24, 2021, Abdul Wahab Mohammed A Alesayi has left the board of directors of AJ Vaccines A/S.
As of January 28, 2021, Jérome Christian Roger Cabannes has stepped down as director of AJ Vaccines A/S.
AJ Vaccines A/S has published its annual report for 2019. Revenue came to DKK 323,471,000, and the net result was DKK -288,603,000.
As of May 28, 2020, Shan-E-Abbas Ashary has joined the board of directors of AJ Vaccines A/S.
As of May 28, 2020, Abdul Wahab Mohammed A Alesayi has joined the board of directors of AJ Vaccines A/S.
As of May 28, 2020, Saddam Abdulqawi Hussein Alhumaikani has joined the board of directors of AJ Vaccines A/S.
As of May 28, 2020, Jesper Helmuth Larsen has left the board of directors of AJ Vaccines A/S.
As of March 23, 2020, Saddam Abdulqawi Hussein Alhumaikani has left the board of directors of AJ Vaccines A/S.
As of July 31, 2019, Jerome Christian Roger Cabannes is registered as director of AJ Vaccines A/S.
As of July 31, 2019, Jérome Christian Roger Cabannes is registered as director of AJ Vaccines A/S.
AJ Vaccines A/S has published its annual report for 2018. Revenue came to DKK 362,192,000, and the net result was DKK -244,490,000.
As of December 20, 2018, Klaus Hermansen has left the board of directors of AJ Vaccines A/S.
As of December 20, 2018, Jesper Helmuth Larsen is registered as adm. dir. of AJ Vaccines A/S.
As of December 20, 2018, Klaus Hermansen has stepped down as adm. dir. of AJ Vaccines A/S.
As of December 19, 2018, Jesper Helmuth Larsen has stepped down as director of AJ Vaccines A/S.
As of September 4, 2018, Jesper Helmuth Larsen has joined the board of directors of AJ Vaccines A/S.
As of September 4, 2018, Saddam Abdulqawi Hussein Alhumaikani has joined the board of directors of AJ Vaccines A/S.
AJ Vaccines A/S has published its interim report for the period September 1, 2016 – December 31, 2017.
As of January 16, 2017, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of AJ Vaccines A/S.
As of January 16, 2017, EY Godkendt Revisionspartnerselskab has stepped down as auditor of AJ Vaccines A/S.
As of January 16, 2017, Klaus Hermansen has joined the board of directors of AJ Vaccines A/S.
As of January 16, 2017, Tabassum Khan has joined the board of directors of AJ Vaccines A/S.
As of January 16, 2017, Mustafa Nasir Farooki has joined the board of directors of AJ Vaccines A/S.
As of January 16, 2017, Helle Birk Krogsgaard has left the board of directors of AJ Vaccines A/S.
As of January 16, 2017, Mie Lund Buhl has left the board of directors of AJ Vaccines A/S.
As of January 16, 2017, Pia Birgitte Lading has left the board of directors of AJ Vaccines A/S.
As of January 16, 2017, Jesper Helmuth Larsen is registered as director of AJ Vaccines A/S.
As of January 16, 2017, Klaus Hermansen is registered as adm. dir. of AJ Vaccines A/S.
As of January 16, 2017, Pia Birgitte Lading has stepped down as director of AJ Vaccines A/S.
As of January 16, 2017, AJ Vaccines Holding ApS is registered as an owner of AJ Vaccines A/S with an ownership share of 100%.
AJ Vaccines A/S has published its interim report for the period August 4, 2016 – August 31, 2016.
As of August 10, 2016, Helle Birk Krogsgaard has joined the board of directors of AJ Vaccines A/S.
As of August 10, 2016, Mie Lund Buhl has joined the board of directors of AJ Vaccines A/S.
As of August 10, 2016, Pia Birgitte Lading has joined the board of directors of AJ Vaccines A/S.
As of August 10, 2016, Ivan Madsen has left the board of directors of AJ Vaccines A/S.
As of August 10, 2016, Poul Jagd Mogensen has left the board of directors of AJ Vaccines A/S.
As of August 10, 2016, Henrik Juul Hansen has left the board of directors of AJ Vaccines A/S.
As of August 10, 2016, Pia Birgitte Lading is registered as director of AJ Vaccines A/S.
As of August 10, 2016, Henrik Juul Hansen has stepped down as adm. dir. of AJ Vaccines A/S.
On August 10, 2016, the company changed its name from Aktieselskabet af august 2016 to AJ Vaccines A/S.
As of August 4, 2016, EY Godkendt Revisionspartnerselskab has been appointed auditor of AJ Vaccines A/S.
As of August 4, 2016, Ivan Madsen has joined the board of directors of AJ Vaccines A/S.
As of August 4, 2016, Poul Jagd Mogensen has joined the board of directors of AJ Vaccines A/S.
As of August 4, 2016, Henrik Juul Hansen has joined the board of directors of AJ Vaccines A/S.
As of August 4, 2016, Henrik Juul Hansen is registered as adm. dir. of AJ Vaccines A/S.
AJ Vaccines A/S was founded on August 4, 2016.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Companies in the same industry and area
CVR 43134477
CVR 36980222
CVR 42790516
CVR 45430324
CVR 45984842
